Skip to Main Content
Services Talent Knowledge
Site Search
Menu

News

July 18, 2023

NY Cannabis Insider: "Decoding the Cannabis Maze: Navigating the Legal Quandaries of THC Variants"

Jason Klimek, Cannabis Team co-leader, had his “Decoding the Cannabis Maze: Navigating the Legal Quandaries of THC Variants” article published by NY Cannabis Insider. The article explores how the different variants of THC have caused confusion regarding whether it’s legal to sell them in New York State. 

Jason’s article explains total THC, which is the metric used by the US Department of Agriculture  and New York State to determine whether a cannabinoid product is hemp or cannabis. The article states, “. . . a hemp plant that is federally legal can have a concentration of no more than 0.3 percent total THC.” Jason explains in greater detail the science behind how certain cannabinoids come to be: some exist naturally in cannabis plants and others are synthesized from CBD. Other cannabinoids can be synthetically produced from non-cannabis materials.

The article makes it clear: “It has never been legal to sell delta-8 or delta-10 THC in New York State without a license . . . . You cannot sell THCA or delta-8, delta-9, or delta 10 THC in New York State without a license. Moreover, you cannot sell THC-O or HCC at all, as they are synthetic cannabinoids and are therefore illegal under both the CSA and New York State law.” 

NY Cannabis Insider subscribers can read the full article here.
 

Subscribe

Click here to sign up for alerts, blog posts, and firm news.

Featured Media

Alerts

EPA Lists Two New "Forever Chemicals" Under CERCLA

Alerts

NYS Governor Hochul Announces Final RFP for New Certified Community Behavioral Health Clinics

Alerts

The Second Department Affirms Successful Storm in Progress Defense of Slip and Fall Case

Alerts

The New York FY 2025 Budget – CDPAP FIs Under Threat

Alerts

Website Accessibility Lawsuits: Several "Tester" Plaintiffs—Anderson, Beauchamp, Murray, Angeles, Monegro, and Bullock—Targeting Businesses in Recent Flurry of Lawsuits

Alerts

Updated Bulletin on Tracking Technologies in the Health Care Industry

We're Growing in DC!

We’re excited to announce Barclay Damon’s combination with Washington DC–based Shapiro, Lifschitz & Schram. SLS’s 10 lawyers, three paralegals, and four administrative staff will join Barclay Damon while maintaining their current office in DC’s central business district. Our clients will benefit from SLS’s corporate, real estate, finance, and construction litigation experience and national energy-industry profile, and their clients from our full range of services.

Read More

This site uses cookies to give you the best experience possible on our site and in some cases direct advertisements to you based upon your use of our site.

By clicking [I agree], you are agreeing to our use of cookies. For information on what cookies we use and how to manage our use of cookies, please visit our Privacy Statement.

I AgreeOpt-Out